Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AUNG BAJAJ

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1598177255
CMS profile
863830
Location
TUCSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$4,389.93

153 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,835.43 150
Consulting Fee $1,375.00 1
Education $179.50 2

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AUNG BAJAJ

NPI 1598177255 · CMS profile ID 863830

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

TUCSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598177255?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AUNG BAJAJ, NPI 1598177255, CMS profile ID 863830. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598177255?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). AUNG BAJAJ, NPI 1598177255, CMS profile ID 863830. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598177255?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
AUNG BAJAJ, NPI 1598177255, CMS profile ID 863830, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1598177255?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

153 matching records · $4,389.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 153 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 153.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $12.7808/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131904915 CMS
E.R. Squibb & Sons, L.L.C. $14.2808/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101271581 CMS
PFIZER INC. $14.9308/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131811040 CMS
ARRAY BIOPHARMA INC $23.4607/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131341212 CMS
PFIZER INC. $19.3307/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131905756 CMS
Celgene Corporation $17.0107/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101095548 CMS
Novartis Pharmaceuticals Corporation $32.2607/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691975 CMS
E.R. Squibb & Sons, L.L.C. $13.1507/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101271579 CMS
ABBVIE INC. $11.3307/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103266543 CMS
Celgene Corporation $24.3307/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101095544 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.7507/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137478858 CMS
Eisai Inc. $19.0107/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110732278 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.1207/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086180274 CMS
Janssen Biotech, Inc. $18.6007/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078284379 CMS
Celgene Corporation $19.6407/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101095546 CMS
PFIZER INC. $18.2407/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131905761 CMS
GlaxoSmithKline, LLC. $13.9407/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115865048 CMS
Sumitomo Pharma America, Inc. $21.6806/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148823831 CMS
Rigel Pharmaceuticals, Inc. $19.0706/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145203879 CMS
Novartis Pharmaceuticals Corporation $22.3506/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691969 CMS
PFIZER INC. $12.6206/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131694968 CMS
Janssen Biotech, Inc. $95.0006/24/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078283679 CMS
Gilead Sciences, Inc. $25.4706/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133804154 CMS
Novartis Pharmaceuticals Corporation $13.2006/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691967 CMS
Sumitomo Pharma America, Inc. $13.6106/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148823829 CMS
Celgene Corporation $21.0206/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101095542 CMS
PFIZER INC. $21.3106/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131326735 CMS
Exelixis Inc. $24.4706/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138555774 CMS
ABBVIE INC. $18.7205/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103266541 CMS
Novartis Pharmaceuticals Corporation $21.0305/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691963 CMS
PFIZER INC. $20.0605/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131324665 CMS
AstraZeneca Pharmaceuticals LP $34.7805/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104627048 CMS
Novartis Pharmaceuticals Corporation $21.8705/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691957 CMS
BeiGene USA, Inc. $21.1105/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120861373 CMS
Lilly USA, LLC $14.4705/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136054330 CMS
Janssen Biotech, Inc. $20.2805/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078285105 CMS
Regeneron Healthcare Solutions, Inc. $16.6905/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114003819 CMS
Lilly USA, LLC $24.0405/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136061520 CMS
Sumitomo Pharma America, Inc. $26.2605/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148823827 CMS
Aveo Pharmaceuticals, Inc. $84.5004/25/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143474063 CMS
GENZYME CORPORATION $25.9404/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139880973 CMS
Novartis Pharmaceuticals Corporation $11.0804/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691953 CMS
Janssen Biotech, Inc. $19.2304/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078283343 CMS
ABBVIE INC. $21.2004/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103266539 CMS
JAZZ PHARMACEUTICALS INC. $27.9204/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150222480 CMS
ARRAY BIOPHARMA INC $22.2704/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131403647 CMS
PharmaEssentia USA Corporation $14.7304/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137302502 CMS
TAIHO ONCOLOGY, INC. $31.8804/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137941862 CMS
Genmab U.S., Inc. $26.8004/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126824629 CMS
Novartis Pharmaceuticals Corporation $9.9904/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086691947 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,443.52 57
PY2020 $210.53 10
PY2021 $223.70 5
PY2022 $2,383.78 53
PY2023 $6,063.80 146
PY2024 $4,389.93 153
PY2025 $1,929.21 77

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $69,315.45 13
PY2024 Principal investigator $159,082.35 13
PY2023 Principal investigator $164,364.70 19
PY2022 Principal investigator $100,228.85 8
PY2021 Principal investigator $11,909.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Exelixis Inc. $2,200.00 12/26/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385842
Principal investigator 1 Exelixis Inc. $2,200.00 12/01/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385844
Principal investigator 1 Exelixis Inc. $1,244.10 11/24/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385836
Principal investigator 1 Exelixis Inc. $8,967.00 11/04/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385838
Principal investigator 1 Exelixis Inc. $4,145.00 11/04/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385840
Principal investigator 1 Exelixis Inc. $7,275.00 10/29/2025 Non-covered Recipient Entity
TMC HEALTHCARE
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222385834
Principal investigator 1 Exelixis Inc. $6,251.15 07/17/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379604
Principal investigator 1 Exelixis Inc. $5,080.70 06/11/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379602
Principal investigator 1 Exelixis Inc. $2,311.15 05/13/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379600
Principal investigator 1 Exelixis Inc. $7,782.85 04/11/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379598
Principal investigator 1 Exelixis Inc. $935.00 03/19/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379592
Principal investigator 1 Exelixis Inc. $19,053.50 02/27/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379596
Principal investigator 1 Exelixis Inc. $1,870.00 01/17/2025 Non-covered Recipient Entity
ARIZONA ONCOLOGY ASSOCIATES
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1222379594